5 hasil untuk "Rui Lin"
Menampilkan 1–5 · 0,40 detik · RSS
-
Artikel Jurnal
Enhancing CO2 Electroreduction to Ethanol on Copper–Silver Composites by Opening an Alternative Catalytic Pathway
A fundamental question in the electrochemical CO 2 reduction reaction (CO 2 RR) is how to rationally control the catalytic selectivity. For instance, adding a CO-selective cocatalyst like Ag to Cu shifts the latter’s CO 2 RR selectivity toward C 2 products, but the underlying cause of the change is…
-
Artikel Jurnal
Hybrid Plasmonic Nanomaterials for Hydrogen Generation and Carbon Dioxide Reduction
The successful development of artificial photosynthesis requires finding new materials able to efficiently harvest sunlight and catalyze hydrogen generation and carbon dioxide reduction reactions. Plasmonic nanoparticles are promising candidates for these tasks, due to their ability to confine…
-
Artikel Jurnal
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Cancer immunotherapy has achieved promising clinical progress over the recent years for its potential to treat metastatic tumors and inhibit their recurrences effectively. However, low patient response rates and dose-limiting toxicity remain as major dilemmas for immunotherapy. Stimuli-responsive…
-
Artikel Jurnal
Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs
Pancreatic cancer continues to be one of the world's most lethal cancers. Chemotherapy resistance in patients with advanced pancreatic cancer often accompany with dismal prognosis, highlighting the need to investigate mechanisms of drug resistance and develop therapies to overcome chemoresistance…
-
Artikel Jurnal
Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
T cells, augmented the efficacy of cancer vaccine immunotherapy, and suppressed HCC progression. Our work presents nanotechnology-enabled dual delivery of siRNA and plasmid DNA that selectively targets and reprograms the immunosuppressive tumor microenvironment to improve cancer immunotherapy.